Kidney Cancer Trial, Recruiting NCT07301827 Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT07301827
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with cancer (tumor subjects):

  • A person or their legal representative is able to read, sign, and date a consent form
  • The person agrees to follow the study procedures for the entire duration of the trial
  • Adults aged 18 or older, of any gender
  • People who have a suspected or confirmed diagnosis of kidney cancer (renal cell carcinoma), based on blood tests, ultrasound, CT, MRI, or tissue samples, and who are in generally good health
  • People whose laboratory test results meet specific requirements set by the trial (confirm with trial site)
  • Women who could become pregnant must have been using contraception for at least one month before the screening visit, and must agree to continue using contraception throughout the study and for a set period after it ends
  • People who meet any additional selection criteria set by the trial (confirm with trial site)

For healthy volunteers:

  • People who fully understand and voluntarily sign the consent form
  • Adults aged 18 to 70, of any gender
  • Men who weigh at least 50 kg and women who weigh at least 45 kg, with a body mass index (BMI) between 19.0 and 26.0
  • People who have had no serious or ongoing conditions affecting the heart, liver, kidneys, lungs, blood, immune system, mental health, nervous system, or digestive system in the past three years, and who are in generally good health
  • People whose vital signs and physical examination results show no abnormalities
  • People who do not plan to have children during the trial or within 6 months after it ends, and who agree to use effective contraception and not donate eggs or sperm during that time
  • People who can communicate clearly with the research team and are willing and able to follow study requirements

Who may not be able to join:

For people with cancer (tumor subjects):

  • People who are unable to complete a PET/MR or PET/CT scan — for example, due to being unable to lie flat, having claustrophobia, or having a fear of radiation
  • People with a known allergy or sensitivity to certain imaging agents used in the scans (targeting PSMA, CAIX, or CD70), or to their ingredients; also, people whose fasting blood sugar level is above 11.0 mmol/L before receiving the imaging agent [18F]FDG
  • People who are pregnant or breastfeeding
  • People who have other circumstances that make participation unsuitable (confirm with trial site)

For healthy volunteers:

  • People who have any serious or unstable health condition, a recent acute illness, or a current or past cancer diagnosis
  • People who are pregnant or breastfeeding
  • People who have had surgery within the 6 months before the trial that the research team considers may affect how the body processes substances
  • People who have taken any medications — including prescription medicines, over-the-counter medicines, or herbal medicines — within the 2 weeks before the trial
  • People who have taken part in another research study involving radioactive materials within the past 12 months
  • People who have any other circumstances that could affect the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0086-027-83692633

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Visual and standardized uptake values assessment of lesions and biodistribution

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov